The impact of the components of metabolic syndrome on heart rate variability: Using the NCEP-ATP III and IDF definitions

PACE - Pacing and Clinical Electrophysiology

Volumn 31, Issue 5, 2008, Pages 584-591

  Min, Kyoung Bok ^a,b   Min, Jin Young ^a   Paek, Domyung ^a   Cho, Sung Il ^a  

^a Seoul National University   (South Korea)

^b Ajou University School of Medicine   (South Korea)

Author keywords

Cardiovascular diseases; Heart rate variability; Prevention; Syndrome X

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; FAMILY HEALTH; FEMALE; HEALTH CARE ORGANIZATION; HEART RATE VARIABILITY; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; METABOLIC SYNDROME X;

ADULT; AGED; AGED, 80 AND OVER; ARRHYTHMIAS, CARDIAC; COMORBIDITY; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; INCIDENCE; INTERNATIONAL CLASSIFICATION OF DISEASES; KOREA; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS;

EID: 42649116100     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2008.01045.x     Document Type: Article

References (33)

1. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005 365 : 1415 1428.
2. Al-Lawati JA, Mohammed AJ, Al-Hinai HQ, Jousilahti P. Prevalence of the metabolic syndrome among Omani adults. Diabetes Care 2003 26 : 1781 1785.
3. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey. JAMA 2002 287 : 356 359.
4. Lim S, Park KS, Lee HK, Cho SI. Changes in the characteristics of metabolic syndrome in Korea over the period 1998-2001 as determined by Korean National Health and Nutrition Examination Surveys. Diabetes Care 2005 28 : 1810 1812.
5. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001 24 : 683 689.
6. Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005 112 : 3066 3072.
7. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: Standards of measurement, physiological interpretation and clinical use. Circulation 1996 93 : 1043 1065.
8. Sinnreich R, Kark JD, Friedlander Y, Sapoznikov D, Luria MH. Five minute recordings of heart rate variability for population studies: Repeatability and age-sex characteristics. Heart 1998 80 : 156 162.
9. Tsuji H, Larson MG, Venditti FJ Jr., Manders ES, Evans JC, Feldman CL, Levy D. Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation 1996 94 : 2850 2855.
10. Gerritsen J, Dekker JM, TenVoorde BJ, Ostense PJ, Heine RJ, Bouter LM, Heethaar RM, et al. Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease: The Hoorn study. Diabetes Care 2001 24 : 1793 1798.
11. Astrup AS, Tarnow L, Rossing P, Hansen BV, Hilsted J, Parving HH. Cardiac autonomic neuropathy predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy. Diabetes Care 2006 29 : 334 339.
12. Liao D, Sloan RP, Cascio WE, Folsom AR, Liese AD, Evans GW, Cai J, et al. Multiple metabolic syndrome is associated with lower heart rate variability. The Atherosclerosis Risk in Communities study. Diabetes Care 1998 21 : 2116 2122.
13. American Heart Association. Heart disease and stroke. Statistics - 2005 update. Available at : http://www.americanheart.org/downloadable/heart/ 1105390918119HDSStats2005Update.pdf. Accessed May 21, 2007.
14. Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: A meta-analysis. Am J Med 2006 119 : 812 819.
15. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001 285 : 2486 2497.
16. Alberti KG, Zimmet P, Shaw J. IDF Epidemiology Task Force Consensus Group. The metabolic syndrome-a new worldwide definition. Lancet 2005 366 : 1059 1062.
17. Jauregui-Renaud K, Hermosillo AG, Marquez MF, Ramos-Aguilar F, Hernandez-Goribar M, Cardenas M. Repeatability of heart rate variability during simple cardiovascular reflex tests on healthy subjects. Arch Med Res 2001 32 : 21 26.
18. WHO Regional Office for the Western Pacific/International Association for the Study of Obesity/International Obesity Task Force, 2000.
19. SAS institute Inc. SAS OnlineDoc, Version 8. Cary, NC : SAS Institute Inc., 1999.
20. Reaven G. Role of insulin resistance in human disease. Diabetes 1998 37 : 1495 1607.
21. Carey D, Jenkins A, Campbell L, Freund J, Chisholm DJ. Abdominal fat and insulin resistance in normal and overweight women: Direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes 1996 45 : 633 638.
22. Goldfine AB, Kahn CR. Adiponectin: Linking the fat cell to insulin sensitivity. Lancet 2003 362 : 1431 1432.
23. Landsberg L. Insulin-mediated sympathetic stimulation: Role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why). J Hypertens 2001 19 : 523 528.
24. Landsberg L, Young JB. Insulin-mediated glucose metabolism in the relationship between dietary intake and sympathetic nervous system activity. Int J Obesity 1985 9 (Suppl 2 63 68.
25. Moller DE, Kaufman KD. Metabolic syndrome: A clinical and molecular perspective. Annu Rev Med 2005 56 : 45 62.
26. Laitinen T, Hartikainen J, Niskanen L, Geelen G, Lansimies E. Sympathovagal balance is major determinant of short-term blood pressure variability in healthy subjects. Am J Physiol 1999 276 : H1245 H252.
27. Laederach-Hofmann K, Mussgay L, Ruddel H. Autonomic cardiovascular regulation in obesity. J Endocrinol 2000 164 : 59 66.
28. Kuch B, Hense HW, Sinnreich R, Kark JD, von Eckardstein A, Sapoznikov D, Bolte HD. Determinants of short-period heart rate variability in the general population. Cardiology 2001 95 : 131 138.
29. Pikkujamsa SM, Huikuri HV, Airaksinen KE, Rantala AO, Kauma H, Lilja M, Savolainen MJ, et al. Heart rate variability and baroreflex sensitivity in hypertensive subjects with and without metabolic features of insulin resistance syndrome. Am J Hypertens 1998 11 : 523 531.
30. Couillard C, Bergeron N, Prud'homme D, Bergeron J, Tremblay A, Bouchard C, Mauriege P, et al. Postprandial triglyceride response in visceral obesity in men. Diabetes 1998 47 : 953 960.
31. Bard JM, Charles MA, Juhan-Vague I, Vague P, Andre P, Safar M, Fruchart JC, et al. Accumulation of triglyceride-rich lipoprotein in subjects with abdominal obesity: The biguanides and the prevention of the risk of obesity (BIGPRO) 1 study. Arterioscler Thromb Vasc Biol 2001 21 : 407 414.
32. Julius S, Jamerson K, Mejia A, Krause L, Schork N, Jones K. The association of borderline hypertension with target organ changes and higher coronary risk. Tecumseh Blood Pressure study. JAMA 1990 264 : 354 358.
33. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr., Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990 15 : 827 832.